Clinical Research Directory
Browse clinical research sites, groups, and studies.
Role of Dexmedetomidine as Synergistic Agent
Sponsor: Lady Reading Hospital, Pakistan
Summary
The aim of this clinical trial is to contribute valuable insights into the role of Dexmedetomidine as a synergistic agent in prolonging subarachnoid block duration, with the overarching goal of enhancing perioperative care and surgical success rates.
Official title: Role of Dexmedetomidine as Synergistic Agent to Prolong a Subarachnoid Block Duration
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
166
Start Date
2024-11
Completion Date
2025-09
Last Updated
2024-10-28
Healthy Volunteers
No
Interventions
Hyperbaric bupivacaine
Group A (Unexposed) will received 2 ml of intrathecal bupivacaine
hyperbaric bupivacaine and dexmedetomidine
Group B (Exposed) will receive a combination of bupivacaine and Dexmedetomidine infusion
Locations (1)
Lady Reading Hospital Mti Peshawar Kp Pakistan
Peshawar, KPK, Pakistan